General Information of Drug (ID: DMUVLC4)

Drug Name
IMGC936 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMUVLC4

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cellular disintegrin-related protein (ADAM9) TTTYQNS ADAM9_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04622774) First-in-Human Study of IMGC936 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of ImmunoGen.